Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-06 5:46 pm Purchase | 2025-02-28 | 13G | Kezar Life Sciences, Inc. KZR | BML Investment Partners, L.P. | 368,594 5.100% | 368,594 (New Position) | Filing History |
| 2025-03-03 4:01 pm Purchase | 2025-02-28 | 13D | Kezar Life Sciences, Inc. KZR | Equal Talent Investments Limited | 616,502 8.660% | 616,502 (New Position) | Filing History |
| 2025-02-14 10:42 am Purchase | 2024-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 502,600 6.900% | 55 (+0.01%) | Filing History |
| 2025-01-16 6:33 pm Sale | 2024-12-03 | 13D | Kezar Life Sciences, Inc. KZR | Morningside Venture Investments Limited | 616,502 8.450% | -8,953 (-1.43%) | Filing History |
| 2024-11-14 12:24 pm Sale | 2024-09-30 | 13G | Kezar Life Sciences, Inc. KZR | BARCLAYS PLC | 0 0.000% | -382,878 (Position Closed) | Filing History |
| 2024-10-08 4:20 pm Purchase | 2024-10-01 | 13D | Kezar Life Sciences, Inc. KZR | TANG CAPITAL MANAGEMENT, LLC | 720,000 9.900% | 720,000 (New Position) | Filing History |
| 2024-07-08 4:32 pm Sale | 2024-06-30 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 83,037 1.100% | -398,690 (-82.76%) | Filing History |
| 2024-02-14 6:47 pm Sale | 2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR | ORBIMED ADVISORS LLC | 192,700 2.700% | -156,812 (-44.87%) | Filing History |
| 2024-02-14 6:44 pm Purchase | 2024-02-13 | 13G | Kezar Life Sciences, Inc. KZR | BARCLAYS PLC | 382,878 5.270% | 382,878 (New Position) | Filing History |
| 2024-02-14 06:50 am Sale | 2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Avidity Partners Management LP | 502,545 6.900% | -175,695 (-25.90%) | Filing History |
| 2024-02-13 11:55 am Purchase | 2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR | SUVRETTA CAPITAL MANAGEMENT, LLC | 716,759 9.900% | 366,333 (+104.54%) | Filing History |
| 2024-02-13 09:50 am Sale | 2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR | Prosight Management LP | 336,533 4.600% | -70,790 (-17.38%) | Filing History |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BlackRock Inc. BLK | 481,727 6.600% | 58,635 (+13.86%) | Filing History |
| 2024-01-23 09:15 am Sale | 2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR | STATE STREET CORP STT | 111,605 1.540% | -313,791 (-73.76%) | Filing History |
| 2024-01-22 4:04 pm Sale | 2023-12-31 | 13G | Kezar Life Sciences, Inc. KZR | MILLENNIUM MANAGEMENT LLC | 292,756 4.000% | -85,297 (-22.56%) | Filing History |
| 2023-08-17 5:14 pm Unchanged | 2023-08-15 | 13D | Kezar Life Sciences, Inc. KZR | Morningside Venture Investments Limited | 625,455 8.600% | 0 (Unchanged) | Filing History |
| 2023-06-21 4:02 pm Purchase | 2023-06-16 | 13G | Kezar Life Sciences, Inc. KZR | MILLENNIUM MANAGEMENT LLC | 378,053 5.200% | 88,404 (+30.52%) | Filing History |
| 2023-04-20 6:20 pm Purchase | 2023-04-11 | 13G | Kezar Life Sciences, Inc. KZR | Prosight Management LP | 407,323 5.800% | 407,323 (New Position) | Filing History |
| 2023-02-14 4:32 pm Purchase | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | ORBIMED ADVISORS LLC | 349,512 5.100% | 349,512 (New Position) | Filing History |
| 2023-02-14 4:20 pm Sale | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BB Biotech AG | 300,000 4.400% | -191,815 (-39.00%) | Filing History |